Fe-curcumin nanozyme-mediated immunosuppression and anti-inflammation in experimental autoimmune uveitis.
Zhengxuan JiangKun LiangXiang GaoFan CaoGuangqi AnSiyu GuiWeiwei TangLiping DuLiming TaoXian-Wen WangPublished in: Biomaterials research (2023)
This study has demonstrated the feasibility of using the Fe-curcumin nanozyme as a nanodrug to inhibit inflammatory reactions and scavenge ROS in the treatment of EAU, indicating that it may serve as a promising therapeutic agent in clinical treatment.